Advanced search
Publication Cover
Molecular & Cellular Oncology Volume 5, 2018 - Issue 4
Submit an article Journal homepage
1,417
Views
1
CrossRef citations to date
0
Altmetric
Author's Views

ZMYND8 is a primary HIF coactivator that mediates breast cancer progression

Yan ChenDepartment of Pathology, UT Southwestern Medical Center, Dallas, Texas, USAView further author information
,
Yingfei WangDepartment of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA;Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, Texas, USAORCID Iconhttp://orcid.org/0000-0002-8723-252XView further author information
ORCID Icon &
Weibo LuoDepartment of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA;Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas, USACorrespondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-1992-0320View further author information
ORCID Icon
Article: e1479619 | Received 06 May 2018, Accepted 07 May 2018, Published online: 01 Aug 2018

References

  • Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol. 2004;381:.335–354. doi:10.1016/S0076-6879(04)81023-1.
  • Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33(4):207–214. doi:10.1016/j.tips.2012.01.005.
  • Luo W, Wang Y. Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity. Cell Mol Life Sci. 2018;75(6):1043–1056. doi:10.1007/s00018-017-2684-9.
  • Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, Kumar A, Wang JE, Wang C, Zou X, et al. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Invest. 2018;128(5):1937–1955. doi:10.1172/JCI95089.
  • Gong F, Chiu LY, Cox B, Aymard F, Clouaire T, Leung JW, Cammarata M, Perez M, Agarwal P, Brodbelt JS, et al. Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. Genes Dev. 2015;29(2):197–211. doi:10.1101/gad.252189.114.
  • Savitsky P, Krojer T, Fujisawa T, Lambert JP, Picaud S, Wang CY, Shanle EK, Krajewski K, Friedrichsen H, Kanapin A, et al. Multivalent histone and DNA engagement by a PHD/BRD/PWWP triple reader cassette recruits ZMYND8 to K14ac-rich chromatin. Cell Rep. 2016;17(10):2724–2737. doi:10.1016/j.celrep.2016.11.014.
  • Choudhry H, Schodel J, Oikonomopoulos S, Camps C, Grampp S, Harris AL, Ratcliffe PJ, Ragoussis J, Mole DR. Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2. EMBO Rep. 2014;15(1):70–76. doi:10.1002/embr.201337642.
  • Adhikary S, Sanyal S, Basu M, Sengupta I, Sen S, Srivastava DK, Roy S, Das C. Selective recognition of H3.1K36 dimethylation/H4K16 acetylation facilitates the regulation of all-trans-retinoic acid (ATRA)-responsive genes by putative chromatin reader ZMYND8. J Biol Chem. 2016;291(6):2664–2681. doi:10.1074/jbc.M115.679985.
  • Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell. 2005;19(4):523–534. doi:10.1016/j.molcel.2005.06.027.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.